Despite ongoing global efforts to improve access to healthcare, many regions still lack commercial availability of life saving essential therapies.

FarmaMondo, a Swiss-based pharmaceutical group, is working to change that paradigm by partnering with biopharma innovators to bring vital medicines to underserved patients in emerging markets.

Headquartered in Switzerland and operating through 14 international affiliates, we offer a one-stop commercialization model supported by over a century of experience. Our scalable and agile operations are locally executed and centrally governed, enabling us to adapt to diverse regulatory and market environments with proven expertise and a strong track record.